Related references
Note: Only part of the references are listed.Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family
K. Azijli et al.
CELL DEATH AND DIFFERENTIATION (2013)
Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand
Nor Saadah M. Azahri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Enhanced Mineralization Potential of Vascular Cells from SM22α-Rankl tg Mice
S. Morony et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: Mechanisms of PDGF-BB-mediated VSMC proliferation and migration
Nor Saadah M. Azahri et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension
Abdul G. Hameed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells
Malene Olesen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Runx2-Upregulated Receptor Activator of Nuclear Factor κB Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages
Chang Hyun Byon et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
Stefano Volpato et al.
ATHEROSCLEROSIS (2011)
Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification
Belinda A. Di Bartolo et al.
CARDIOVASCULAR RESEARCH (2011)
The RANKL/RANK/OPG Signaling Pathway Mediates Medial Arterial Calcification in Diabetic Charcot Neuroarthropathy
Agbor Ndip et al.
DIABETES (2011)
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe-/- mice
B. A. Di Bartolo et al.
DIABETOLOGIA (2011)
Cell-specific effects of TNF-α and IL-1β on alkaline phosphatase: implication for syndesmophyte formation and vascular calcification
Philippe Lencel et al.
LABORATORY INVESTIGATION (2011)
RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells
Ling-Qing Yuan et al.
PLOS ONE (2011)
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Vascular Calcification
Maud Chasseraud et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Myeloid CD34+ CD13+ Precursor Cells Transdifferentiate into Chondrocyte-Like Cells in Atherosclerotic Intimal Calcification
Lars Christian Doehring et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Estrogen Inhibits Vascular Calcification via Vascular RANKL System Common Mechanism of Osteoporosis and Vascular Calcification
Mariana Kiomy Osako et al.
CIRCULATION RESEARCH (2010)
TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2-, Sp1 Phosphorylation-, and NFκB-Dependent Manner
Jeffrey Chan et al.
CIRCULATION RESEARCH (2010)
PKA-induced Receptor Activator of NF-κB Ligand (RANKL) Expression in Vascular Cells Mediates Osteoclastogenesis but Not Matrix Calcification
Wendy Tseng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Inhibition of Receptor Activator of NF-κB Ligand by Denosumab Attenuates Vascular Calcium Deposition in Mice
Susann Helas et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4-Dependent Pathway
Sara Panizo et al.
CIRCULATION RESEARCH (2009)
Smooth Muscle Cells Give Rise to Osteochondrogenic Precursors and Chondrocytes in Calcifying Arteries
Mei Y. Speer et al.
CIRCULATION RESEARCH (2009)
Death receptors and their ligands in atherosclerosis
Mary M. Kavurma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Mineral Surface in Calcified Plaque Is Like That of Bone Further Evidence for Regulated Mineralization
Melinda J. Duer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Expression, regulation and function of trail in atherosclerosis
Mary M. Kavurma et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(-/-) mice
Sean Morony et al.
CIRCULATION (2008)
TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-κB and induction of insulin-like growth factor-1 receptor
Mary M. Kavurma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells
Antonio R. G. Susperregui et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
PPAR-γ regulates osteoclastogenesis in mice
Yihong Wan et al.
NATURE MEDICINE (2007)
Differential expression of TRAIL and its receptors relative to calcification in AAA
Xun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Vascular calcification - Pathobiological mechanisms and clinical implications
Rebecca C. Johnson et al.
CIRCULATION RESEARCH (2006)
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice
Paola Secchiero et al.
CIRCULATION (2006)
TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque
K Sato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of bone-regulating factors osteoprotegerin (OPG) and receptor activator of NF-κB ligand (RANKL) in heterotopic vascular ossification
N Al-Fakhri et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Bone morphogenetic proteins in vascular calcification
KA Hruska et al.
CIRCULATION RESEARCH (2005)
Calcification of advanced atherosclerotic lesions in the innominate arteries of ApoE-deficient mice - Potential role of chondrocyte-like cells
M Rattazzi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ:: implications for diffuse intimal calcification
YV Bobryshev
JOURNAL OF PATHOLOGY (2005)
TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis
SW Lee et al.
ARTHRITIS AND RHEUMATISM (2004)
Patterns and risk factors for systemic calcified atherosclerosis
MA Allison et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
The role of cytokines in cartilage matrix degeneration in osteoarthritis
SR Goldring et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-κB ligand in Monckeberg's sclerosis and atherosclerosis
M Schoppet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin
P Collin-Osdoby
CIRCULATION RESEARCH (2004)
Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease
AM Sattler et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulate aortic valve calcification
JJ Kaden et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction
CA Gregory et al.
ANALYTICAL BIOCHEMISTRY (2004)
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
G Zauli et al.
BLOOD (2004)
Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads
TM Doherty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-β1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression
MH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased osteoprotegerin serum levels in men with coronary artery disease
M Schoppet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Vascular calcification and its relation to bone calcification: Possible underlying mechanisms
N Mody et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2003)
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
S Jono et al.
CIRCULATION (2002)
Activation of peroxisome proliferator-activated receptor γ inhibits osteoprotegerin gene expression in human aortic smooth muscle cefls
MG Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
M Schoppet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D
PA Price et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis
P Collin-Osdoby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cellular interactions and signaling in cartilage development
AM DeLise et al.
OSTEOARTHRITIS AND CARTILAGE (2000)
Assay for human matrix Gla protein in serum -: Potential applications in the cardiovascular field
LAJLM Braam et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
